Objective: To present relevant and updated information on the status of hypothyroidism in the pediatric population (newborn infants to adolescents).
Introduction
Deficiency in the production or in the activity of thyroid hormones (TH) leads to hypothyroidism, one of the most frequent hormone diseases in children. The first known description of this syndrome dates back to 1874, by Gull; the name myxedema was defined by Ord in 1878. The term myxedema was used for several years to refer to the disease, although Haliburton, in 1893, emphasized the fact that many patients did not present that sign. 1 Clinical conditions resulting from TH deficiency will depend on the degree and duration of the deficiency, and will affect basically all tissues to a lower or greater extent. However, it is during intrauterine life that the lack of adequate TH production determines more damaging consequences, since these hormones have a fundamental role in normal fetal brain development. 2 The advent of molecular biology brought significant advances regarding information on the disease, including elucidations regarding its etiology, which may have an origin during intrauterine life. In the past 3 decades, knowledge about the otogenesis, pathophysiology and early diagnosis of hypothyroidism have grown strongly, and early diagnosis has allowed for intervention on the first days of life of newborn infants (NB), thus preventing damage to neuropsychomotor development. For an adequate TH production, it is important that the hypothalamic-pituitarythyroid axis be maintained whole so as to ensure the sequence of activities of the hypothalamic releasing hormone (thyrotropin-releasing hormone -TRH) over the pituitary gland, producing thyroid-stimulating hormone (TSH), which in turn acts on the thyroid, producing TH. Deficiencies in these stages lead to tertiary (hypothalamic), secondary (pituitary) or primary (thyroid) hypothyroidism.
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Physiology
Iodine is an essential element for the synthesis of TH, the only substances in our body that contain iodine in their configuration. Dietary sources of iodine include bread, iodized salt and dairy products. The recommended daily intake of iodine is of at least 75 µg/day, which corresponds to 10 g of iodized salt, according to recommendations of the World Health Organization (one part of sodium iodide in 100,000 parts of NaCl). 5 Inorganic iodine present in circulation enters the thyroid follicular cells, where it is organified. This transport depends on the TSH and on a sodium-iodide symporter (NIS), which is located in the membrane of the thyroid cells. The thyroid has a limited capacity to use iodides. 3 In normal conditions, thyroid iodide clearance rates are higher than organification rates (iodide incorporation into amino acids).
Progressively higher concentrations of extracellular iodide increase its transport into the cell until organification reaches its maximum rate; then a sudden decrease is observed, a short-duration phenomenon known as Wolff-Chaikoff effect.
After tyrosine organification, the formation of monoiodotyrosines (MIT) and diiodotyrosines (DIT) already incorporated into thyroglobulin will take place. These hormones will couple to form two main TH: triiodothyronine (T3) and tetraiodothyronine (T4 Reverse T3 (rT3) derives from the peripheral monodeiodination of T4.
Mechanism of action of thyroid hormones
Most part of the biological effects associated with TH are However, these signs and symptoms are not always evident, and a precious time can sometimes be wasted before treatment is started. This is why the performance of laboratory tests in the nursery room is so important.
Delayed neuropsychomotor development and growth are observed, body proportions are abnormal, and the lower limbs are short if compared to the trunk.
When hypothyroidism is acquired at a later stage, mental retardation may be less evident, but growth will be affected, and these children will present a delay in bone maturation or bone age. In adolescents, hypothyroidism clinical features may show a slower evolution, with tiredness, difficulties at school, intestinal obstipation, dry skin and hair, hair loss, brittle nails, intolerance to cold weather and decreased appetite (it is important to emphasize that obesity is not a characteristic of hypothyroidism). Girls may present menstrual irregularities, and an increase in menstrual cycle periods are more common than amenorrhea. Other endocrine alterations may also be observed in hypothyroidism. Some adolescents may present sexual infantilism, and paradoxically, some others may present precocious puberty. In the long term, thyrotroph hypertrophy may be observed, with an increase in the pituitary gland and in the sella turcica.
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Differential diagnosis
Differential diagnosis should include Down syndrome, Beckwith syndrome, mucopolysaccharidoses, chondrodystrophies, hypopituitarism, and obesity. It is always important to take into consideration that hypothyroidism is very rarely associated with obesity. Table 1 presents the classification and prevalence of congenital hypothyroidism according to Fisher. 9 Hypothyroidism manifestations in practically all tissues do not depend on its etiology, but rather on the degree of hormone deficiency.
Congenital hypothyroidism: classification
The causes of thyroid agenesis remain unknown, but there is evidence suggesting an association with mutations in some transcription factors, such as TTF1, TTF2 and PAX8, which are important in thyroid gland embryogenesis.
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Neonatal screening
Neonatal screening (heel prick test) should be performed in the nursery room, ideally between 3 and 5 days after birth. 
Subclinical hypothyroidism
This denomination applies to asymptomatic patients presenting normal T3 and T4 levels and slightly high TSH levels.
This type of hypothyroidism is considered to be mild and to represent a risk factor for evolution to overt hypothyroidism and other dysfunctions. Diagnostic implications start with the definition of normal TH levels, more specifically TSH levels.
The accepted cut-off point for normal TSH levels is 4 to 5 mU/L, which has been conventionally used to diagnose high concentrations of TSH. 20 Some studies have considered lower cut- TSH levels should be monitored carefully to prevent them from going below normal, since T3 and T4 stimulate bone resorption and increase the number of osteoblasts.
If parameters contraindicating treatment are found, it is recommended that clinical and laboratory assessments be carried out every 6 months.
Transient hypothyroidism
In this situation, hormone levels behave similarly as in primary hypothyroidism, that is, low T4 levels and high TSH lev- 
Incidence
CLT is considered to be the most common thyropathy among children and adolescents, and it is recognized as the main cause of nontoxic goiter. In an American population with age between 11 and 18 years, five new cases were detected out of 1,000 adolescents screened every year. The incidence is higher among girls, varying from 4:1 to 8:1 depending on the geographical region covered. The disease is rare before 4 years of age and is frequent between 10 and 11 years.
Clinical features
The presence of goiter is one of the main complaints. and who present a progressive cognitive decline should be assessed. Although the etiology is unknown, a good response to steroid medications suggests an inflammatory or autoimmune dysfunction. 22, 23 Antibodies are considered important markers for the identification of patients who will benefit from an efficient treatment with glucocorticoids.
Laboratory features of hypothyroidism
The diagnosis of congenital hypothyroidism can be confirmed based on T4 and TSH dosages. In the neonatal period,
i.e., between 1 and 4 weeks of life, T4 levels < 6.5 µg/dL and TSH levels > 10 mU/L are suggestive of congenital hypothyroidism.
Hypothalamic-pituitary hypothyroidism is characterized by low levels of T4 and normal or even low levels of TSH.
Decreased TSH response during the TRH test suggests a diagnosis of central hypothyroidism.
Male children with low total T4 and normal TSH levels should undergo assessment of free T4 and TBG values. This situation may be related with TBG deficiency in normal children, who thus should not be treated for hypothyroidism. The presence of thyroglobulin in serum indicates parenchymal lesion and may be a tumor marker. 22, 23 Thyroid ultrasound will always be an important laboratory test for the purposes of diagnosis and follow-up. Images
showing an irregular texture in the parenchyma are suggestive of thyroiditis. The presence of nodules or cysts deserves special attention in order to discard the possibility of carcinomas. 24, 25 Two and 24-hour thyroidal radioactive isotope uptake tests TH replacement is the simplest among all hormone replacement therapies. The drug of choice is levothyroxine (L-T4 sodium salt), which allows measuring serum T4 levels to assess the efficacy of treatment and adjusting doses.
Levothyroxine has a mean life of 7 days, and the maximum response is reached in the second week of treatment, when great part of T3 will have been converted. It is administered once a day in the morning. Table 2 shows the recommended doses for different age groups.
These doses may change according to laboratory variations. They should be adjusted whenever signs of overdose are observed: irritability, inability to sleep, red areas on the skin, diarrhea, tachycardia, and sweatiness. Breastfed infants submitted to high doses of levothyroxine may develop craniostenosis.
Since these children may present some degree of psychomotor disorder, they should be followed by professionals from the areas of speech therapy, physical therapy and psichopedagogy. 27 
